NCT04534413View on ClinicalTrials.gov

Ex-Vivo COF Study for Lung Cancer Observation

Enrolling by invitationOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

December 5, 2026

Study Completion Date

December 5, 2026

Conditions

Lung Cancer

Interventions

DEVICE

composite optical fiberscope (COF)

Fiber Technology

Trial Locations (1)

M5G 1L7

Toronto General Hospital, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER